AsttraZeneca Pharmaceuticals LP
AsttraZeneca Pharmaceuticals LP appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0444-2025, Class II) was initiated on May 14, 2025.
Summary
- Total Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0444-2025 | Class II | Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) | May 14, 2025 |